Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review
Endocrine Oncology and Metabolism · 2016
DOI: 10.21040/eom/2016.2.3.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Oncology and Metabolism, 2016. Verfasst von Miriam Čupić und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Čupić, M., Dumančić, J., Potočnjak, I., Klobučar, I., Trbušić, M., & Degoricija, V. (2016). Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review. Endocrine Oncology and Metabolism. https://doi.org/10.21040/eom/2016.2.3.6
Vancouver
Čupić M, Dumančić J, Potočnjak I, Klobučar I, Trbušić M, Degoricija V. Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review. Endocrine Oncology and Metabolism. 2016. doi:10.21040/eom/2016.2.3.6
BibTeX
@article{upi2016,
author = {Čupić, Miriam and Dumančić, Jelena and Potočnjak, Ines and Klobučar, Iva and Trbušić, Matias and Degoricija, Vesna},
title = {Metabolic acidosis: expected and fatal adverse effects of metformin and empagliflozin: a case series and literature review},
journal = {Endocrine Oncology and Metabolism},
year = {2016},
doi = {10.21040/eom/2016.2.3.6}
}
EUVIMED